Ceesay Abraham sold RAPP
September 23, 2026 · Form 4 insider transaction
Ceesay Abraham sold 43 shares of Rapport Therapeutics, Inc. at $41.05 per share, a transaction worth $1.8K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
43
Price
$41.05
Total value
$1.8K
InsiderCeesay Abraham
RoleOfficer, Director
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateSeptember 23, 2026
Filing dateSeptember 24, 2026
Shares owned after456,767
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
These transactions were effected by the Reporting Person pursuant to Rule 10b5-1 trading plans adopted on March 27, 2026.